http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfe4b641f521fc2089dee553c2c61842
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Wang |
| name | Ena Wang |
| given-name | Ena |
| organization-name | Authors' Affiliations: 1University of Hawai'i Cancer Center, 2John A. Burns School of Medicine, University of Hawai'i, Honolulu, Hawaii; 3San Raffaele University and Research Institute, Milano, Italy; 4Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland; and 5Department of Cardiothoracic Surgery, NYU School of Medicine, New York Authors' Affiliations: Divisions of 1Cancer Epidemiology and Genetics and 2Cancer Treatment and Diagnosis, 3Center for Cancer Research, National Cancer Institute, NIH, Department of Health and Human Services, and 4Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center and Center for Human Immunology, NIH, Department of Health and Human Services, Bethesda, Maryland; 5Center for Health Sciences, SRI International, Menlo Park, California; and 6EPOCA, Epidemiology Research Center, University of Milan, and Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy Immunnogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA Authors' Affiliations: 1Division of Cancer Epidemiology and Genetics and 2Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, and 3Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center and Center for Human Immunology, NIH, Department of Health and Human Services, Bethesda, Maryland Allogene, South San Francisco, CA, 94080, USA. ewang911@gmail.com. Research Branch, Sidra Medical and Research Center Doha Qatar Allogene Therapeutics, South San Francisco, CA, USA. ewang911@gmail.com. Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, CC, and trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, MD 20892. Qatar Computing Research Institute, Doha, Ad Dawhah, Qatar 1Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, Infectious Disease & Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center & Center for Human Immunology, NIH, R-1C711, Building 10, 9000 Rockville Pike, Bethesda, MD 20892, USA. Authors' Affiliations: 1Martin-Luther-Universitat Halle-Wittenberg, Institute of Medical Immunology, Halle (Saale), 2University of Tuebingen, 2nd Department of Internal Medicine, Tuebingen Ageing and Tumor Immunology Group (TATI), Section for Transplantation Immunology and Immunohaematology, Centre for Medical Research, Tuebingen, Germany; 3University of Pittsburgh Cancer Institute, Departments of Surgery, Immunology, and Pathology, Cancer Immunology Program, School of Medicine, Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania; 4NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis, Rockville, 5Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Center for Human Immunology (CHI), NIH, Bethesda, Maryland Sidra Medical and Research Centre, Doha, Qatar Department of Transfusion Medicine, Infectious Disease and Immunogenetics Section, National Institutes of Health, Bethesda, MD, 20892 4 †Surgery Branch, National Cancer Institute, Authors' Affiliations: 1Department of Medicine/Division of Hematology-Oncology, 2Department of Surgery/Division of Surgical Oncology and the Human Immune Therapy Center, Cancer Center, University of Virginia Health System, Charlottesville, Virginia; 3Division of Cancer Treatment and Diagnosis, National Cancer Institute, and 4Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and trans-NIH Center for Human Immunology (CHI), NIH, Bethesda, Maryland Infectious Disease and Immunogenetics Section (IDIS) Department of Transfusion Medicine Clinical Center and Center for Human Immunology (CHI) NIH Bethesda MD USA *Surgery Branch, 5Sidra Medical and Research Centre, Doha, Qatar. Authors' Affiliation: Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland 1Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland; Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, and Center for Human Immunology, National Institutes of Health, Bethesda, MD 20892; National Institutes of Health, Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, 9000 Rockville Pike, Bethesda, MD 20892, USA. 3Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. Trans‐NIH Center for Human Immunology, Autoimmunity and Inflammation National Institutes of Health Bethesda MD USA; Department of Transfusion Medicine Clinical Center National Institutes of Health Bethesda MD USA 7National Institutes of Health, Bethesda, Maryland.; 8Sidra Medical and Research Centre, Doha, Qatar. Laboratory Services Section, Department of Transfusion Medicine, Office of Deputy of Clinical Care, Clinical Center National Institutes of Health Bethesda Maryland 9Sidra Medical and Research Center, Doha, Qatar. Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20892, USA. EWang@maill.cc.nih.gov Sidra Medical and Research Center, PO Box 26999, Doha, Qatar From the Immunogenetics Section of the Department of Transfusion Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, MD; Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke (NINDS), NIH, Bethesda, MD; and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD. Authors' Affiliations: 1Department of Medicine, Division of Hematology/Oncology, 2Department of Surgery, Division of Surgical Oncology, 3Jonsson Comprehensive Cancer Center, 4Department of Ophthalmology and the Jules Stein Eye Institute, 5Department of Medicine, Division of Dermatology, and 6Department of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, California; 7Infectious Disease and Immunogenetics Section and Center for Human Immunology, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland; and 8Pfizer Global Research and Development, New London, Connecticut Division of Translational Medicine, Research Branch, Sidra Medical and Research Center, Doha, Qatar *Surgery Branch, Division of Clinical Sciences, National Cancer Institute, and 1Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, 1Department of Medicine, Division of Hematology/Oncology; 2Department of Surgery, Division of Surgical Oncology; 3Department of Neurosurgery; 4Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, California; 5Department of Medicine, Division of Dermatology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California; and 6Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland 1Immunogenetics Section, Department of Transfusion Medicine, NIH, Bethesda, Maryland and Departments of Sidra Medical and Research Center, Doha, Ad Dawhah, Qatar Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD Infectious Disease & Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center & trans-NIH Center for Human Immunology (CHI), National Institutes of Health, Bethesda, MD 20892, USA 3Immunogenetics Laboratory, Department of Transfusion Medicine, NIH, Bethesda, Maryland; Department of Transfusion Medicine National Institutes of Health Bethesda MD USA; Sidra Medical and Research Centre Doha Qatar Infectious Disease and Immunogenetics Section (IDIS) Department of Transfusion Medicine Clinical Center and trans‐NIH Center for Human Immunology (CHI) National Institutes of Health Bethesda Maryland *Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892 Authors' Affiliations: Divisions of 1Cancer Epidemiology and Genetics, and 2Cancer Treatment and Diagnosis, NCI/NIH; 3Department of Transfusion Medicine, Clinical Center and Center for Human Immunology, NIH, Bethesda, Maryland; 4School of Public Health, Yale University, New Haven, Connecticut; and 5Unit of Epidemiology, Fondazione IRCCS Ospedale Maggiore Policlinico and Department of Occupational and Environmental Health, Università degli Studi di Milano, Milan, Italy Department of Transfusion Medicine; National Institutes of Health; Bethesda MD †Department of Transfusion Medicine, Infectious Disease and Immunogenetics Section, Clinical Center, and Center for Human Immunology, National Institutes of Health, Bethesda, MD 20892; and Department of Tumor Biology, Immunology and Therapy, Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar Sidra Medical and Research Center, Qatar Foundation, Doha, Qatar Department of Transfusion Medicine, Clinical Center, National Institutes of Health Authors' Affiliations: 1Unit of Immuno-biotherapy of Melanoma and Solid Tumors, Division of Molecular Oncology; 2Neural Stem Cell Biology Unit, Division of Regenerative Medicine Stem Cells and Gene Therapy; 3Department of Pathology; and 4Unit of Neurosurgery, San Raffaele Foundation Scientific Institute, Milan, Italy; 5Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, and Center for Human Immunology NIH, Bethesda, Maryland; and 6University of Pittsburgh Cancer Institute, Departments of Surgery, of Immunology and of Pathology, Pittsburgh, Pennsylvania National Institutes of Health, Bethesda, MD 2Immunogenetics Laboratory, Department of Transfusion Medicine; 2Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland Authors' Affiliation: Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland *Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine and 9Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. Department of Transfusion Medicine, Infectious Disease and Immunogenetics Section, Clinical Center, and trans-National Institutes of Health Center for Human Immunology, National Institutes of Health, Bethesda, MD 20892; and Immunogenetics Section of the Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD, USA. Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, Maryland 20892, USA. Sidra Medical and Research Center, Doha, Qatar 4 5Immunogenetics Section, Department of Transfusion Medicine, NIH, Bethesda, Maryland National Institutes of Health, Department of Transfusion Medicine, Building 10, Room 1C711, Clinical Center, Bethesda, MD 20892, USA. Immunogenetics Section, The Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA Authors' Affiliations: 1Laboratory of Genetic Medicine and Immunology; 2Genomics Core; 3Biomarkers Unit, Weill Cornell Medical College in Qatar - Qatar Foundation; Departments of 4Laboratory Medicine and Pathology and 5Surgery, Hamad Medical Corporation, Doha, Qatar; 6Department of Molecular Pharmacology, Physiology, and Biotechnology and Center for Biomedical Engineering, Brown University, Providence, Rhode Island; and 7Department of Transfusion Medicine, Infectious Disease and Immunogenetics Section, Clinical Center, and Trans-National Institutes of Health Center for Human Immunology, NIH, Bethesda, Maryland †Surgery Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 From the Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda MD; Tumor Immunology Laboratory, Division of Surgical Oncology, Columbia University, New York, NY; and Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA. *Surgery Branch and Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, CC, and Trans-NIH Center for Human Immunology (CHI), NIH, Bethesda, Maryland, USA; Sidra Medical and Research Centre, Doha, Qatar *Surgery Branch, Division of Clinical Sciences, National Cancer Institute, Cellular Therapy and Immunogenetics Sections, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA. |
Incoming Links
Total number of triples: 360.